COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 163 filers reported holding COHERUS BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 1.41 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,931 | +26.7% | 5,864 | +44.7% | 0.00% | 0.0% |
| Q2 2023 | $17,306 | -48.6% | 4,053 | -4.6% | 0.00% | -50.0% |
| Q4 2022 | $33,652 | -17.6% | 4,249 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $40,833 | +32.7% | 4,249 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $30,763 | -43.9% | 4,249 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $54,855 | -80.7% | 4,249 | -76.1% | 0.00% | -50.0% |
| Q4 2021 | $284,295 | -0.7% | 17,813 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $286,255 | +23.3% | 17,813 | +12.1% | 0.00% | +33.3% |
| Q1 2021 | $232,197 | -24.9% | 15,893 | -10.7% | 0.00% | -40.0% |
| Q4 2020 | $309,173 | -14.7% | 17,789 | -12.3% | 0.01% | -16.7% |
| Q2 2020 | $362,451 | -13.8% | 20,294 | -2.2% | 0.01% | -14.3% |
| Q3 2019 | $420,294 | +11.4% | 20,745 | +21.5% | 0.01% | +16.7% |
| Q2 2019 | $377,269 | +62.0% | 17,071 | 0.0% | 0.01% | +50.0% |
| Q1 2019 | $232,848 | +50.7% | 17,071 | 0.0% | 0.00% | +33.3% |
| Q4 2018 | $154,493 | -54.2% | 17,071 | +1.5% | 0.00% | +50.0% |
| Q3 2015 | $337,000 | – | 16,813 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |